Nile Pharmaceuticals and Chemical Industries Company (EGX:NIPH)
Egypt · Delayed Price · Currency is EGP 266.51
-2.49 (-0.93%)
At close: Oct 22, 2026
EGX:NIPH Balance Sheet
Financials in millions EGP. Fiscal year is July - June.
Millions EGP. Fiscal year is Jul - Jun.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 18.55 | 21.16 | 34.35 | 21.44 | 53.57 |
Cash & Short-Term Investments | 18.55 | 21.16 | 34.35 | 21.44 | 53.57 |
Cash Growth | -12.29% | -38.41% | 60.25% | -59.99% | -51.13% |
Accounts Receivable | 312.18 | 271.85 | 87.82 | 164.93 | 99.54 |
Other Receivables | 34.71 | 30.25 | 108 | 49.12 | 37.56 |
Receivables | 1,057 | 487.05 | 351.75 | 420.67 | 304.23 |
Inventory | 621.67 | 524.8 | 446.98 | 409.76 | 240.04 |
Prepaid Expenses | - | - | - | 0.16 | 0.21 |
Other Current Assets | 54.06 | 140.42 | 16.61 | 17.92 | 9.09 |
Total Current Assets | 1,751 | 1,173 | 849.69 | 869.96 | 607.15 |
Property, Plant & Equipment | 1,434 | 1,139 | 615.15 | 159.98 | 153.88 |
Long-Term Investments | 15.01 | 8.35 | 8.35 | 8.35 | 8.35 |
Total Assets | 3,200 | 2,321 | 1,473 | 1,038 | 769.38 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 204.46 | 118.49 | 157.11 | 164.08 | 135.21 |
Accrued Expenses | 103.01 | 79.06 | 70.43 | 72.72 | 62.35 |
Short-Term Debt | 1,134 | 639.29 | 241.78 | 154.38 | 79.78 |
Other Current Liabilities | 197.5 | 365.35 | 196.55 | 106.7 | 57.34 |
Total Current Liabilities | 1,639 | 1,202 | 665.87 | 497.88 | 334.68 |
Long-Term Debt | 422.11 | 349.43 | 333.5 | 58.12 | - |
Long-Term Deferred Tax Liabilities | 68.91 | 25.79 | 4.97 | 3.81 | 3.83 |
Total Liabilities | 2,130 | 1,577 | 1,004 | 559.81 | 338.52 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 500 | 300 | 101.25 | 101.25 | 101.25 |
Retained Earnings | 546.68 | 424.2 | 347.2 | 357.13 | 310.16 |
Comprehensive Income & Other | 24.25 | 19.09 | 20.41 | 20.11 | 19.46 |
Shareholders' Equity | 1,071 | 743.29 | 468.86 | 478.48 | 430.87 |
Total Liabilities & Equity | 3,200 | 2,321 | 1,473 | 1,038 | 769.38 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 1,556 | 988.73 | 575.28 | 212.49 | 79.78 |
Net Cash (Debt) | -1,537 | -967.57 | -540.93 | -191.06 | -26.21 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -30.74 | -32.25 | -53.42 | -18.87 | -2.59 |
Filing Date Shares Outstanding | 50 | 30 | 10.13 | 10.13 | 10.13 |
Total Common Shares Outstanding | 50 | 30 | 10.13 | 10.13 | 10.13 |
Working Capital | 112.61 | -28.76 | 183.82 | 372.08 | 272.47 |
Book Value Per Share | 21.42 | 24.78 | 46.31 | 47.26 | 42.55 |
Tangible Book Value | 1,071 | 743.29 | 468.86 | 478.48 | 430.87 |
Tangible Book Value Per Share | 21.42 | 24.78 | 46.31 | 47.26 | 42.55 |
Land | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 |
Buildings | 493.96 | 555.82 | 142.34 | 139.56 | 139.56 |
Machinery | 1,177 | 594.57 | 266.77 | 263.52 | 259.33 |
Construction In Progress | 168.89 | 325.89 | 535.67 | 79.45 | 67.57 |